• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The development and initial validation of a sensitive bedside cognitive screening test.

作者信息

Faust D, Fogel B S

机构信息

Department of Psychology, Rhode Island Hospital, Providence 02903.

出版信息

J Nerv Ment Dis. 1989 Jan;177(1):25-31. doi: 10.1097/00005053-198901000-00004.

DOI:10.1097/00005053-198901000-00004
PMID:2642534
Abstract

Brief bedside cognitive examinations such as the Mini-Mental State Examination are designed to detect delirium and dementia but not more subtle or delineated cognitive deficits. Formal neuropsychological evaluation provides greater sensitivity and detects a wider range of cognitive deficits but is too lengthy for efficient use at the bedside or in epidemiological studies. The authors developed the High Sensitivity Cognitive Screen (HSCS), a 20-minute interview-based test, to identify patients who show disorder on formal neuropsychological evaluation. An initial study demonstrated satisfactory test-retest and interrater reliability. The HSCS was then administered to 60 psychiatric and neurological patients with suspected cognitive deficits but without gross impairment, who also completed formal neuropsychological testing. Results of both tests were independently classified as either normal, borderline, or abnormal. The HSCS correctly classified 93% of patients across the normal-abnormal dichotomy and showed promise for characterizing the extent and severity of cognitive dysfunction.

摘要

相似文献

1
The development and initial validation of a sensitive bedside cognitive screening test.
J Nerv Ment Dis. 1989 Jan;177(1):25-31. doi: 10.1097/00005053-198901000-00004.
2
Bedside cognitive screening instruments. A critical assessment.床边认知筛查工具。批判性评估。
J Nerv Ment Dis. 1986 Feb;174(2):73-83. doi: 10.1097/00005053-198602000-00002.
3
[Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].[HIV感染中的认知障碍。一种简短神经心理学评估量表的验证]
Encephale. 1995 Jul-Aug;21(4):289-94.
4
The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.一份用于评估神经精神疾病患者认知功能的照料者调查问卷的开发与验证
J Psychosom Res. 2007 Jul;63(1):93-8. doi: 10.1016/j.jpsychores.2007.02.004.
5
Mini-mental state examination in neurological patients.神经病患者的简易精神状态检查
J Neurol Neurosurg Psychiatry. 1984 May;47(5):496-9. doi: 10.1136/jnnp.47.5.496.
6
The high sensitivity cognitive screen.高灵敏度认知筛查
Int Psychogeriatr. 1991 Winter;3(2):273-88. doi: 10.1017/s1041610291000728.
7
The HIV Dementia Scale: predictive power in mild dementia and HAART.HIV痴呆量表:在轻度痴呆和高效抗逆转录病毒治疗中的预测能力。
J Neurol Sci. 2007 Sep 15;260(1-2):11-5. doi: 10.1016/j.jns.2006.03.023. Epub 2007 May 4.
8
Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.蒙特利尔认知评估量表优于简易精神状态检查用于检出脑卒中后认知障碍吗?一项神经心理学评估研究。
Stroke. 2011 Jun;42(6):1712-6. doi: 10.1161/STROKEAHA.110.606277. Epub 2011 Apr 7.
9
The Barrow Neurological Institute screen for higher cerebral functions in cognitive screening after stroke.巴罗神经学研究所(美国)在脑卒中后的认知筛查中对高级大脑功能进行筛查。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):349-55. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.026. Epub 2013 May 28.
10
Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.帕金森病的认知筛查:帕金森神经心理痴呆评估(PANDA)与其他3种简短量表的比较
Rev Neurol (Paris). 2016 Feb;172(2):138-45. doi: 10.1016/j.neurol.2015.08.004. Epub 2015 Oct 20.

引用本文的文献

1
Cancer-related cognitive impairment in breast cancer survivors: An examination of conceptual and statistical cognitive domains using principal component analysis.乳腺癌幸存者中与癌症相关的认知障碍:使用主成分分析对概念性和统计性认知领域的考察。
Oncol Rev. 2018 Aug 28;12(2):371. doi: 10.4081/oncol.2018.371. eCollection 2018 Jul 4.
2
Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.绝经前期和围绝经期乳腺癌女性化疗后的认知功能和生活质量。
Support Care Cancer. 2018 Feb;26(2):575-583. doi: 10.1007/s00520-017-3869-3. Epub 2017 Aug 28.
3
Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
全脑放射治疗后行调强增敏治疗联合同步替莫唑胺治疗非小细胞肺癌脑转移瘤。
Clin Transl Oncol. 2014 Nov;16(11):1000-5. doi: 10.1007/s12094-014-1190-x. Epub 2014 Jun 4.
4
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.银杏叶提取物预防接受乳腺癌辅助治疗的女性化疗相关认知功能障碍的应用,N00C9。
Support Care Cancer. 2013 Apr;21(4):1185-92. doi: 10.1007/s00520-012-1647-9. Epub 2012 Nov 13.
5
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study.辅助 FOLFOX 化疗在结肠癌患者中无化疗脑效应。一项初步研究。
Support Care Cancer. 2013 Feb;21(2):583-90. doi: 10.1007/s00520-012-1560-2. Epub 2012 Aug 11.
6
An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.用于评估乳腺癌幸存者化疗后认知变化的神经心理学测试评估。
Support Care Cancer. 2012 Jul;20(7):1361-75. doi: 10.1007/s00520-012-1445-4. Epub 2012 Apr 5.
7
A framework for assessment in oncology rehabilitation.肿瘤康复评估框架。
Phys Ther. 2009 Mar;89(3):286-306. doi: 10.2522/ptj.20070309. Epub 2009 Jan 15.
8
Assessing cognitive function in cancer patients.评估癌症患者的认知功能。
Support Care Cancer. 2006 Nov;14(11):1111-8. doi: 10.1007/s00520-006-0037-6. Epub 2006 Mar 15.
9
A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment.
J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1510-7. doi: 10.1136/jnnp.57.12.1510.